In a patient with postural orthostatic tachycardia syndrome (POTS) who has low cortisol levels, how should adrenal insufficiency be confirmed and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Low Cortisol in POTS: Diagnosis and Management

Low cortisol levels in POTS patients do not indicate true adrenal insufficiency—the adrenal glands respond normally to stimulation in POTS, and routine testing for adrenal insufficiency is not warranted unless there is a clear history of glucocorticoid use or other specific risk factors.

Understanding the Relationship Between POTS and Cortisol

POTS is fundamentally a disorder of autonomic dysfunction, not adrenal insufficiency. Research demonstrates that adrenal gland responsiveness to ACTH stimulation is completely intact in POTS patients 1. When challenged with both low-dose (1 μg) and high-dose (249 μg) ACTH, POTS patients showed aldosterone and cortisol responses identical to healthy controls, with peak cortisol levels around 40 μg/dL and aldosterone around 50-60 ng/dL 1.

Interestingly, some studies show that cortisol levels may actually be elevated in POTS patients (160.17 pg/ml) compared to controls (69.65 pg/ml), likely reflecting the chronic stress response associated with the condition 2. This contradicts the premise that POTS causes low cortisol.

When to Actually Test for Adrenal Insufficiency

Do not routinely test for adrenal insufficiency in POTS patients. However, testing is appropriate if:

Glucocorticoid-Related Risk Factors Present:

  • Recent glucocorticoid use (within past year) at supraphysiologic doses
  • Current use of inhaled/topical glucocorticoids for >1 year
  • Intra-articular glucocorticoid injections within 2 months
  • Multiple simultaneous glucocorticoid formulations
  • Concomitant strong CYP3A4 inhibitors (azole antifungals, ritonavir) 3

Classic Adrenal Insufficiency Symptoms:

  • Severe fatigue (beyond typical POTS fatigue)
  • Nausea/vomiting (20-62% of AI cases)
  • Anorexia and weight loss (43-73%)
  • Hyperpigmentation (primary AI only)
  • Hypotension with hyponatremia 4

Diagnostic Algorithm When Testing is Indicated

Step 1: Morning Serum Cortisol (8 AM)

Obtain early morning cortisol, ACTH, and DHEAS simultaneously 4:

  • Cortisol >10 μg/dL (>300 nmol/L): Adrenal insufficiency excluded 3
  • Cortisol 5-10 μg/dL (150-300 nmol/L): Indeterminate—proceed to Step 2
  • Cortisol <5 μg/dL (<150 nmol/L): Highly suggestive of AI—proceed to Step 2

Step 2: ACTH Stimulation Test (if cortisol <10 μg/dL)

Administer cosyntropin 250 μg IV/IM, measure cortisol at 60 minutes 4:

  • Peak cortisol >18 μg/dL: Normal response (though newer assays suggest 15.6 μg/dL may be adequate) 5
  • Peak cortisol <18 μg/dL: Confirms adrenal insufficiency

Interpretation of ACTH and DHEAS:

  • High ACTH + Low DHEAS: Primary adrenal insufficiency
  • Low/normal ACTH + Low/normal DHEAS: Secondary or glucocorticoid-induced AI 4

Management if Adrenal Insufficiency is Confirmed

Glucocorticoid Replacement:

  • Hydrocortisone 15-25 mg daily divided into 2-3 doses (preferred)
  • Alternative: Prednisone 3-5 mg daily 6, 4
  • Avoid long-acting glucocorticoids (dexamethasone) due to adverse effects 6

Mineralocorticoid Replacement (Primary AI Only):

  • Fludrocortisone 0.05-0.2 mg daily 6, 4
  • Do NOT use fludrocortisone in glucocorticoid-induced AI 3

Stress Dosing Education:

All patients with confirmed AI must receive:

  • Instructions to double or triple glucocorticoid dose during acute illness
  • Injectable hydrocortisone 100 mg IM for emergency use
  • Medical alert identification 4

Critical Pitfalls to Avoid

  1. Do not assume low cortisol in POTS equals adrenal insufficiency—the adrenal axis is intact 1

  2. Do not test for AI while patient is on supraphysiologic glucocorticoids—wait until dose is tapered to physiologic levels 3

  3. Do not perform dynamic testing routinely in glucocorticoid taper—morning cortisol is sufficient 3

  4. Do not use fludrocortisone for glucocorticoid-induced AI—only for primary AI 3

  5. Recognize that POTS-related hypovolemia is NOT due to adrenal insufficiency—it results from autonomic dysfunction affecting venous pooling and plasma volume regulation 7, 8

The Bottom Line for POTS Patients

POTS itself does not cause adrenal insufficiency. If a POTS patient has truly low cortisol levels, investigate for separate causes: prior glucocorticoid exposure, pituitary pathology, or autoimmune adrenalitis. The vast majority of POTS patients have normal or even elevated cortisol responses and should not receive glucocorticoid therapy, which could worsen their condition through volume retention and cardiovascular effects 1, 2.

References

Related Questions

How should beta‑blockers be used to treat postural orthostatic tachycardia syndrome (POTS)?
In a 15-year-old girl with postural orthostatic tachycardia syndrome (POTS) who is taking mirtazapine for decreased appetite and insomnia, how should the medication be managed regarding dosing, monitoring, and possible alternatives?
Is my 1.4 cm pineal cyst the cause of my left facial twitching with transient eye drooping, chronic migraines, and the multiple comorbid conditions (hypothyroidism, endometriosis, irritable bowel syndrome–mixed, asthma, thoracic outlet syndrome, postural orthostatic tachycardia syndrome, hiatal hernia with a wide‑open valve, and iron‑deficiency anemia)?
What does the acronym POTS (Postural Orthostatic Tachycardia Syndrome) stand for?
With an initial standing blood pressure of 124/82 mmHg and heart rate of 115 bpm, and after five minutes of standing a blood pressure of 112/77 mmHg and heart rate of 110 bpm, does this still meet criteria for postural orthostatic tachycardia syndrome (POTS)?
What is the most common cause of death in patients with peptic ulcer disease?
How should painful urination in a 4-year-old child be evaluated and managed?
Do peanuts trigger gout attacks?
Should peptide injections be used only under physician supervision, and what are the associated risks?
What is the significance of a urine protein‑creatinine ratio of 213 mg/g and what evaluation and management steps are recommended?
Is Voltaren gel (diclofenac) safe for use in a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.